Click here for slides on this topic


Bariatric surgery

Bariatric surgery, or weight-loss surgery, includes a variety of procedures aimed at reducing weight among people who are obese. The size of the stomach is reduced with a gastric band or via excision of a portion of the stomach, or by re-secting and re-routing the small intestines to a stomach pouch. 

 


The following content matched the glossary term: Bariatric surgery

AHA ADA prevention of CVD in T2D - Metabolic Bariatric Surgery for Weight Management

Top

Summary of recommendations for bariatric surgery for obese patients from the AHA ADA cardiovascular disease (CVD) prevention in type 2 diabetes guidelines.

AACE 2015 guidelines Obesity Management

Top

Summary of the obesity treatment algorithm, including pharmacologic therapy and bariatric surgery, from the 2015 AACE diabetes guidelines 

Endocrine Society obesity clinical practice guideline

Top

Summary of guidelines for managing obesity with pharmacologic therapy from the Endocrine Society.

Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications

Top

Sjöström L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014;311(22):2297-2304.

Bariatric surgery versus intensive medical therapy for diabetes–3-year outcomes

Top

Schauer PR, Bhatt DL, Kirwan JP, et al; for the STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes–3-year outcomes. N Engl J Med. 2014. doi: 10.1056/NEJMoa1401329.

ADA 2016 Type 2 Diabetes Pharmacologic Therapy

Top

Pharmacologic treatment options for type 2 diabetes from the 2016 ADA guidelines

Clinical Insights in Diabetes Newsletter October 2013

Top

Clinical Insights® in Diabetes newsletter October 2013

Exploring DPP-4 CV safety in SAVOR-TIMI 53 and EXAMINE, CV outcomes in Look AHEAD, relationship between gastric bypass and A1C and cardiometabolic risk factors, metabolic effects of bariatric surgery and medical therapy in STAMPEDE, statin use and diabetes risk, severe hypoglycemia and CVD disease risk.

European Association for the Study of Diabetes (EASD) 49th Annual Meeting 2013 - Bariatric Surgery Reduces Diabetes Complications 20 Years Out

Top

NDEI's coverage of the European Association for the Study of Diabetes (EASD) 49th Annual Meeting 2013 from Barcelona, Spain

 

European Association for the Study of Diabetes (EASD) 49th Annual Meeting 2013

Top

NDEI's coverage of the European Association for the Study of Diabetes (EASD) 49th Annual Meeting 2013 from Barcelona, Spain

1 2 Next 

Slide Library Results

Search Results for: Bariatric surgery Slides Found: 67
NHLBI Guidelines for Treatment of Obesity
Malabsorptive Surgery: Outcomes
Bariatric Surgery: Gastrorestrictive Procedures
Gastrorestrictive Surgery: Outcomes
Laparoscopy and Liposuction
Effect of Bariatric Surgery on Acute Insulin Response
Quality of Life After Bariatric Surgery: Nottingham Health Profile (NHP)
Bariatric Surgery: Conclusions
STAMPEDE: Design
STAMPEDE Results: Primary Endpoint (A1C ≤6%) at 12 Months
Bariatric Surgery for Obesity
Roux-en-Y Gastric Bypass Surgery in Type 2 Diabetes and Mild Obesity: Glycemic Control Results
Roux-en-Y Gastric Bypass Surgery in Type 2 Diabetes and Mild Obesity: Design
SOS Analysis: Interaction Between Risk Factors and Treatment
SOS Analysis: Sensitivity Analyses; Adverse Events
RYGB Surgery: Long-Term Health-Related Outcomes Design
SOS Post-hoc Analysis: Effect of Bariatric Surgery on CV Events
SOS Post-hoc Analysis: Total CV Events in Obese Subjects with Type 2 Diabetes
SOS Post-hoc Analysis: MI in Obese Subjects with Type 2 Diabetes
SOS Post-hoc Analysis: Stroke in Obese Subjects with Type 2 Diabetes
STAMPEDE Metabolic Substudy: A1C Improvement in All Groups at 24 Months
STAMPEDE Metabolic Substudy: Greater Reduction in Truncal Fat with Gastric Bypass Vs Sleeve Gastrectomy
STAMPEDE Metabolic Substudy: Greater Increases in Insulin Sensitivity, Beta-Cell Function with Gastric Bypass
STAMPEDE Metabolic Substudy: Design
LABS-2: 3-Yr Weight Loss After Bariatric Surgery
LABS-2: 3-Yr Mortality After Bariatric Surgery
LABS-2: 3-Yr Remission & Incidence of Cardiometabolic Outcomes After Bariatric Surgery
Teen-LABS: Rates of Complications 30 Days After Bariatric Surgery
AHA/ACC/TOS Obesity Guidelines: Bariatric Surgery Outcomes
AHA/ACC/TOS Obesity Guidelines: Predictors of Weight Loss With Bariatric Surgery
AHA/ACC/TOS Obesity Guidelines: Bariatric Surgery Complications
AHA/ACC/TOS Obesity Guidelines: Complications Seen With Bariatric Surgery
AHA/ACC/TOS: Candidates for Bariatric Surgery
AHA/ACC/TOS Obesity Guidelines: Assessing BMI & Determining Readiness for Lifestyle Changes
AHA/ACC/TOS Obesity Guidelines: Treatment Algorithm for Overweight & Obese Adults Committed to Weight Loss
AHA/ACC/TOS Obesity Guidelines: Treatment Algorithm for Achieving & Maintaining Weight Loss
STAMPEDE: A1C Less Than or Equal to 6.0 Percent at 3 Yrs With Bariatric Surgery Vs Medical Therapy
Incretins Sulfonylureas Pancreatitis Risk Type 2 Diabetes | NDEI
Incretins Pancreatitis Risk Sulfonylureas Type 2 Diabetes Use Duration | NDEI
Incretins Sulfonylureas Pancreatitis Risk Type 2 Diabetes Gender | NDEI
Incretin Therapies Vs Sulfonylureas Pancreatitis Type 2 Diabetes | NDEI
Bariatric Surgery Type 2 Diabetes Remission SOS Study | NDEI
Bariatric Surgery Type 2 Diabetes Complications SOS Study | NDEI
SOS Analysis: Rate of Diabetes Incidence by Subgroup
SOS Analysis: Rate of Diabetes Incidence
SOS Analysis: Mean Baseline Characteristics
SOS Analysis: Design
Bariatric Surgery Type 2 Diabetes Weight Loss | NDEI
SOS Study Bariatric Surgery Type 2 Diabetes Design | NDEI
Diabetes & Aging Study Type 2 Diabetes Remission PPT Slide | NDEI
Diabetes & Aging Study Type 2 Diabetes Remission Summary | NDEI
Teen-LABS CVD Risk in Adolescents Undergoing Bariatric Surgery | NDEI
AMOS Study Bariatric Surgery for Adolescents With Severe Obesity | NDEI
Bariatric Surgery & Long-Term Survival in Veterans Severe Obesity | NDEI
Effect of Bariatric Surgery on Type 2 Diabetes Medication Use | NDEI
Safety Bariatric Surgery for BMI <35 at 1 Year
Does Bariatric Surgery Influence Type 2 Diabetes Development PPT | NDEI
Incidence of Type 2 Diabetes After Bariatric Surgery Obesity PPT | NDEI
Bariatric Metabolic Surgery for Weight Loss Type 2 Diabetes AHA ADA | NDEI
Bariatric Surgery for Weight Loss in Type 2 Diabetes for CVD Prevention | NDEI
Bariatric Surgery in Type 2 Diabetes ADA Guidelines | NDEI PPT
Type 2 Diabetes Treatment Algorithm for Metabolic (Bariatric) Surgery | NDEI
Metabolic Surgery for Type 2 Diabetes Treatment Guidelines PPT | NDEI
Patient Selection Metabolic Surgery for Type 2 Diabetes Treatment Guidelines | NDEI
Metabolic Surgery Procedures for Treating Type 2 Diabetes Guidelines | NDEI
Metabolic Surgery Postoperative Follow-Up for Type 2 Diabetes Guidelines | NDEI
Preoperative Workup Metabolic Surgery for Type 2 Diabetes Treatment | NDEI